Oakbrook Investments’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-8,250
Closed -$720K 293
2019
Q4
$720K Sell
8,250
-8,950
-52% -$765K 0.15% 211
2019
Q3
$1.28M Buy
17,200
+7,600
+79% +$614K 0.08% 180
2019
Q2
$816K Sell
9,600
-6,440
-40% -$517K 0.05% 298
2019
Q1
$1.38M Sell
16,040
-1,100
-6% -$89.5K 0.08% 185
2018
Q4
$1.09M Sell
17,140
-2,010
-10% -$131K 0.07% 207
2018
Q3
$1.32M Buy
19,150
+11,725
+158% +$805K 0.07% 239
2018
Q2
$497K Buy
+7,425
New +$508K 0.03% 353
2018
Q1
Sell
-15,755
Closed -$1.49M 592
2017
Q4
$1.49M Sell
15,755
-325
-2% -$34K 0.09% 157
2017
Q3
$1.88M Buy
16,080
+3,350
+26% +$424K 0.12% 142
2017
Q2
$1.6M Buy
+12,730
New +$1.62M 0.11% 152
2015
Q3
Sell
-2,125
Closed -$221K 546
2015
Q2
$221K Buy
+2,125
New +$220K 0.01% 501

Other funds holding INCY

Oakbrook Investments's INCY Position: Q1 2020 in Review

Oakbrook Investments sold out of Incyte (INCY) in Q1 2020, closing a stake of 8,250 shares — an estimated $720K sold.

Oakbrook Investments first reported a position in INCY in Q2 2015 and held it in 11 quarters. The position peaked at $1.88M in Q3 2017. 490 funds tracked by Wall St. Rank hold INCY as of Q1 2020.

  • Oakbrook Investments reported no remaining Incyte position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 8,250 Incyte shares in Q1 2020, an estimated $720K.
  • Oakbrook Investments first reported a position in Incyte in Q2 2015 and held it in 11 quarters.
  • Oakbrook Investments's Incyte position peaked at $1.88M in Q3 2017.
  • 490 funds tracked by Wall St. Rank held Incyte as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.